BROWN MICHAEL S
SEC CIK 1174475 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 1,703 | — | $24.54M | 29 | 2021-08-09 | 2026-01-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
| 19 | BROWN MICHAEL S | Dir | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +155 | 1,703 | +10% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +166 | 1,548 | +12% | $0 |
| D | 2024-06-17 | 2024-06-14 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $625.60 | +1,535 | 2,917 | +111% | +$960.3K |
| D | 2024-06-17 | 2024-06-14 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $1,040.00 | -1,535 | 1,382 | -53% | -$1.60M |
| D | 2024-05-29 | 2024-05-28 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $625.60 | +1,172 | 2,554 | +85% | +$733.2K |
| D | 2024-05-29 | 2024-05-28 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $974.86 | -1,172 | 1,382 | -46% | -$1.14M |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| D | 2023-12-29 | 2023-12-27 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $482.68 | +2,049 | 3,296 | +164% | +$989.0K |
| D | 2023-12-29 | 2023-12-27 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $898.00 | -2,049 | 1,247 | -62% | -$1.84M |
| D | 2023-04-24 | 2023-04-21 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $520.01 | +3,070 | 4,317 | +246% | +$1.60M |
| D | 2023-04-24 | 2023-04-21 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $798.42 | -3,070 | 1,247 | -71% | -$2.45M |
| D | 2023-02-08 | 2023-02-06 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $798.00 | -3,071 | 1,247 | -71% | -$2.45M |
| D | 2023-02-08 | 2023-02-06 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $520.01 | +3,071 | 4,318 | +246% | +$1.60M |
| DI | 2023-02-08 | 2023-02-06 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $797.00 | -500 | 6,162 | -8% | -$398.5K |
| D | 2023-01-30 | 2023-01-27 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $747.00 | -1 | 1,247 | -0.1% | -$747 |
| D | 2023-01-30 | 2023-01-27 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $520.01 | +1 | 1,248 | +0.1% | +$520.01 |
| D | 2023-01-10 | 2023-01-06 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $747.14 | -3,070 | 1,247 | -71% | -$2.29M |
| D | 2023-01-10 | 2023-01-06 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $520.01 | +3,070 | 4,317 | +246% | +$1.60M |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +165 | 1,247 | +15% | $0 |
| DM | 2022-11-10 | 2022-11-08 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $755.18 | -3,995 | 1,749 | -70% | -$3.02M |
| DI | 2022-11-10 | 2022-11-08 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $748.49 | -500 | 6,662 | -7% | -$374.2K |
| DM | 2022-11-10 | 2022-11-08 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $416.62 | +3,995 | 3,513 | New | +$1.66M |
| DM | 2022-03-31 | 2022-03-29+ | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $374.12 | +1,930 | 1,490 | New | +$722.1K |
| DM | 2022-03-31 | 2022-03-29+ | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $699.00 | -1,930 | 1,082 | -64% | -$1.35M |
| I | 2022-02-24 | 2022-02-23 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale | $608.68 | -500 | 7,162 | -7% | -$304.3K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| DM | 2021-09-15 | 2021-09-13 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale+OE | $648.16 | -9,704 | 6,465 | -60% | -$6.29M |
| DM | 2021-09-15 | 2021-09-13 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | M - OptEx | $405.06 | +9,704 | 10.6K | +1,089% | +$3.93M |
| I | 2021-08-10 | 2021-08-09 | REGN | Regeneron Pharmaceuticals | BROWN MICHAEL S | Dir | S - Sale | $612.38 | -1,687 | 7,662 | -18% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations